In today’s Pharmaceutical Executive Daily, we report on new data showing Wegovy’s potential to reduce liver injury in patients with MASH, Eli Lilly’s latest strategic collaborations in gene therapy, ...

The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

P opular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

What Happened: According to Reuters, Pfizer Inc (NYSE: PFE) won the bidding war against Novo Nordisk and will purchase ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

By Rishika Sadam BENGALURU (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.

Danish drugmaker Novo Nordisk has cut the price of its weight-loss drug Wegovy by up to 33% in India, a key battleground for ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...